Nonprofits step up to protect fertility for cancer patients Roshni Kamta remembers that spring day two years ago when she left for work on her usual crowded New York City subway line, carrying precious cargo. Inside the light white bag, which she stored inside the refrigerator at work, were her egg freezing supplies — syringes […]
Read More
Choosing better lung cancer treatments with machine learning © iStock-Jackie Niam Researchers say that machine learning could help guide healthcare workers’ treatment decisions for lung cancer patients after developing a model that is 71% more accurate at predicting survival expectancy of patients. A team of Penn State Great Valley researchers conducted a study in which […]
Read More
Actress Tamannaah’s pledge to help Devika ‘Fightagainstcancer’ with Tring Mumbai (Maharashtra) [India], February 19 (ANI/NewsVoir): With a call for the generous hearts to step ahead and contribute, Tamannaah has associated with Tring’s Icons for Change initiative to support a cause that is extremely close to her heart. The actress went live to garner donations for […]
Read More
Novel Additions Require Nuanced Treatment Selection in Relapsed/Refractory Myeloma Knowledge of prior therapies a patient has received, adequate prophylactic treatment, and consistent monitoring for unique toxicities is necessary to ensure patients are able to derive optimal benefit from novel options that have explored in relapsed/refractory myeloma therapy, according to Parameswaran Hari, MD, MRCP. “My approach […]
Read More
Octapharma: New Consensus Recommendations on Treatment of Secondary Antibody Deficiency … LACHEN, Switzerland–(BUSINESS WIRE)–New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and secondary antibody deficiencies (SAD) were recently published in the European Journal of Haematology. The publication, sponsored by Octapharma, marks the first pan-European consensus guidance […]
Read More
Benefits and problems of allogeneic stem cell transplantation as multiple myeloma treatment Prof Kröger talks to ecancertv at ICMM 2016 about the standard treatment of multiple myeloma in younger patients. In particular, he highlights both the benefits and complications associated with allogeneic stem cell transplants.
Read More